Loading…
Replimune Group, Inc. is projected to rise to $6.10 by 2027, a +30% move from its current price of $4.70. REPL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $4.29 | $4.70 | $5.15 | +0.04% |
| May 30 | $4.13 | $4.70 | $5.35 | +0.07% |
| May 31 | $4.02 | $4.70 | $5.51 | +0.11% |
| Jun 1 | $3.92 | $4.71 | $5.65 | +0.14% |
| Jun 2 | $3.84 | $4.71 | $5.78 | +0.18% |
| Jun 3 | $3.77 | $4.71 | $5.89 | +0.21% |
| Jun 4 | $3.70 | $4.71 | $6.00 | +0.25% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.70 | $4.71 | $6.00 | +0.25% |
| Week 2 | $3.36 | $4.72 | $6.65 | +0.49% |
| Week 3 | $3.12 | $4.73 | $7.20 | +0.74% |
| Week 4 | $2.93 | $4.75 | $7.70 | +0.99% |
| Week 5 | $2.77 | $4.76 | $8.17 | +1.24% |
| Week 6 | $2.64 | $4.77 | $8.62 | +1.49% |
| Week 7 | $2.52 | $4.78 | $9.06 | +1.74% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Replimune Group, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of oncolytic immunotherapies to treat cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors.
The company is also developing RP2 that express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3, which express immune-activating proteins that stimulate T cells.
Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
REPL is the stock ticker for Replimune Group, Inc. The current price is $4.91. The market capitalization stands at $405.43M and the stock ranks 3215.
Forecasts show an upside path with a rising average price over time: 2026 avg $4.91; 2027 avg $6.32; 2030 avg $8.29; 2040 avg $43.83; 2050 avg $65.00, with bullish sentiment indicated in the later years.
A major floor 89.1% below — a decisive break under it would weaken the trend.
The nearest floor, 60.4% below — buyers have tended to step in here.
The nearest ceiling, 12.8% above — a clean break opens room to run.
A major ceiling 83.8% above — clearing it would confirm fresh momentum.
Key REPL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of REPL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.92 | Sell | $4.80 | Sell |
| MA 10 | $4.97 | Sell | $4.69 | Buy |
| MA 20 | $4.09 | Buy | $4.41 | Buy |
| MA 50 | $4.73 | Sell | $4.82 | Sell |
| MA 100 | $6.24 | Sell | $5.77 | Sell |
| MA 200 | $6.77 | Sell | $6.80 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.29 | Neutral |
| Stoch RSI (14) | 46.51 | Neutral |
| CCI (20) | 45.97 | Neutral |
| Williams %R (14) | -30.61 | Info |
| MACD (12,26,9) | 0.14 | Buy |
| ROC (12) | 15.48 | Buy |
| Bollinger %B (20,2) | 0.65 | Neutral |
| Stochastic %K (14) | 69.39 | Neutral |
| TRIX (15) | 0.31 | Buy |
| Awesome (5,34) | 1.40 | Buy |
| Ultimate (7,14,28) | 47.06 | Neutral |
| Momentum (10) | 0.61 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 4.76 | Sell |
| ADX (14) | 17.92 | Neutral |
| ATR (14) | 0.35 | Info |
Technical picture is bullish. RSI14 is 60, indicating positive momentum.
The SMA50 is $4.83 and the SMA200 is $6.78, with near-term support at $1.70 and resistance at $5.30.
The 30-day range is $2.61 to $9.25, and annualized volatility is 200%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.70 | $4.70 | $6.60 | 0% | Neutral | |
| $4.39 | $6.10 | $9.18 | +30% | Bullish | |
| $4.78 | $7.05 | $11.26 | +50% | Bullish | |
| $4.49 | $6.97 | $11.68 | +48% | Bullish | |
| $5.05 | $8.21 | $14.32 | +75% | Bullish | |
| $6.66 | $11.31 | $20.41 | +141% | Bullish | |
| $9.26 | $16.42 | $30.52 | +249% | Bullish | |
| $10.07 | $18.58 | $35.49 | +295% | Bullish | |
| $10.09 | $19.37 | $37.92 | +312% | Bullish | |
| $11.23 | $22.40 | $44.86 | +377% | Bullish | |
| $20.74 | $46.08 | $101.35 | +880% | Bullish | |
| $31.56 | $70.13 | $161.30 | +13.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.70 | $4.70 | $5.56 | +0.00% |
| June 2026 | $3.86 | $4.63 | $5.75 | -1.47% |
| July 2026 | $3.98 | $4.85 | $6.19 | +4.79% |
| August 2026 | $3.97 | $4.91 | $6.38 | +1.11% |
| September 2026 | $3.69 | $4.62 | $6.09 | -5.90% |
| October 2026 | $3.62 | $4.57 | $6.11 | -1.13% |
| November 2026 | $3.78 | $4.81 | $6.52 | +5.44% |
| December 2026 | $3.75 | $4.82 | $6.60 | +0.08% |
Click any year to see its month-by-month REPL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Replimune Group, Inc.'s 2026 outlook centres on $4.70, within a $1.70 to $6.60 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, REPL could reach as high as $9.18, with a base case around $6.10 and support toward $4.39 — roughly +30% from $4.70. Buyers look set to stay in control over this stretch.
Expect REPL to range from $4.78 to $11.26 through 2028. The $7.05 average target implies a +50% move from current prices. That is up +15% on the projected 2027 average. Momentum favours further upside here.
The REPL price prediction for 2029 points to an average of $6.97 (low $4.49, high $11.68) — a potential gain of +48% on today's $4.70. Buyers look set to stay in control over this stretch.
In 2030, REPL is projected to trade between $5.05 and $14.32, averaging $8.21 — a potential gain of +75% from today's $4.70. That is up +18% on the projected 2029 average. Momentum favours further upside here.
Replimune Group, Inc.'s 2031 outlook centres on $11.31, within a $6.66 to $20.41 range. That is up +38% on the projected 2030 average. That marks a +141% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, REPL could reach as high as $30.52, with a base case around $16.42 and support toward $9.26 — roughly +249% from $4.70. Momentum favours further upside here.
Expect REPL to range from $10.07 to $35.49 through 2033. The $18.58 average target implies a +295% move from current prices. That is up +13% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The REPL price prediction for 2034 points to an average of $19.37 (low $10.09, high $37.92) — a potential gain of +312% on today's $4.70. Momentum favours further upside here.
In 2035, REPL is projected to trade between $11.23 and $44.86, averaging $22.40 — a potential gain of +377% from today's $4.70. That is up +16% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Replimune Group, Inc.'s 2040 outlook centres on $46.08, within a $20.74 to $101.35 range. That is up +106% on the projected 2035 average. That marks a +880% change versus current levels. Momentum favours further upside here.
By 2050, REPL could reach as high as $161.30, with a base case around $70.13 and support toward $31.56 — roughly +13.9x from $4.70. Buyers look set to stay in control over this stretch.
Investing $1,000 in REPL today (≈ 212.765957 REPL) could be worth
$14,921.29
+$13,921.29 (+1392%) by 2050 · US Dollar
Based on the average projected REPL price of $70.13 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in REPLwould be worth at today's price.
$1,000 invested in REPL on May 27, 2025 (≈ 118.764845 REPL) would be worth
$558.19
-$441.81 (-44.2%) today · 0.56× · US Dollar
Based on a REPL entry price of $8.42 vs. today's $4.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.16 | $910.85 | -8.9% |
| 1 month ago | $2.68 | $1,753.73 | +75.4% |
| 3 months ago | $7.69 | $611.18 | -38.9% |
| 6 months ago | $10 | $470 | -53.0% |
| 1 year ago | $8.42 | $558.19 | -44.2% |
| All time (5.0y) ago | $37.27 | $126.11 | -87.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our REPL forecast.
Our base-case forecast reaches $9.40 around 2031.
Implied market cap at $9.40: $776.18M
Over the multi-year horizon, the forecast shows bullish sentiment across the forward years. The 2027 average is $6.32 with ROI 28.7% and a bullish stance; 2030 average is $8.29 with ROI 68.8% and bullish sentiment. The 2040 average is $43.83 with ROI 792.7% and bullish sentiment, and the 2050 average is $65.00 with ROI 1223.8% and bullish sentiment.
The forecast also provides higher-end views: 2030 max $14.46, 2040 max $96.43, 2050 max $149.50. These figures illustrate potential upside under the modeled scenarios, but they are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $8.29; Min $5.09; Max $14.46; ROI 68.8%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with an average path toward $65.00 by 2050 and ROI up to 1223.8%, but these are estimates, not guarantees.
Yes, the forecast max by 2050 is $149.50.
Current price is $4.91 and market cap is $405.43M.
Low $2.61, High $9.25.
Replimune Group, Inc. Community Discussion
0Share your Replimune Group, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.